Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | HPGD | P15428 | 3/20 | 0.48 |
| ▸ | CA12 | O43570 | 4/20 | 0.44 |
| ▸ | CA9 | Q16790 | 4/20 | 0.44 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | APEX1 | P27695 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 3/20 | 0.37 |
| ▸ | PYGL | P06737 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3628031 | 0.93 | POLB (0.41) | ALDH1A1HPGDCA12CA9CA2 | |
| SCHEMBL1224664 | 0.90 | ALDH1A1 (0.56) | ALDH1A1HPGDCA12CA9CA2 | |
| SCHEMBL18435281 | 0.87 | ALDH1A1 (0.54) | ALDH1A1HPGDCA12CA9CA2 | |
| SCHEMBL7719427 | 0.86 | CA12 (0.48) | ALDH1A1HPGDCA12CA9CA2 | |
| SCHEMBL8635207 | 0.86 | ALDH1A1 (0.45) | ALDH1A1HPGDCA12CA9CA2 | |
| SCHEMBL16159995 | 0.86 | ALDH1A1 (0.48) | ALDH1A1HPGDCA12CA9CA2 | |
| SCHEMBL13246033 | 0.85 | CA12 (0.42) | ALDH1A1CA12CA9CA2TSHR | |
| SCHEMBL8632384 | 0.84 | ALDH1A1 (0.57) | ALDH1A1HPGDCA12CA9CA2 | |
| SCHEMBL134968 | 0.83 | ALDH1A1 (0.46) | ALDH1A1HPGDCA12CA9CA2 | |
| SCHEMBL1396575 | 0.83 | ALDH1A1 (0.37) | ALDH1A1HPGDCA12CA9CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5851274-A | Ink jet ink compositions and processes for high resolution and high speed printing | XEROX CORPORATION (US) | 1998-12-22 | — | — | US | claimed |
| EP-0853107-A1 | Ink jet ink compositions comprising hydroxyamide derivatives and printing processes | XEROX CORPORATION (US) | 1998-07-15 | — | — | EP | claimed |
| EP-0853108-A1 | Ink jet ink compositions and processes for high resolution and high speed printing | XEROX CORPORATION (US) | 1998-07-15 | — | — | EP | claimed |
| US-5693129-A | AQUEOUS MIXCTURE CONTAINING COLORING AND A HYDROXYAMIDE, THIOAMIDE, MERCAPTOAMIDE, MERCAPTOTHIOAMIDE OR AN OXYALKYLENE OR A THIOALKYLENE REACTION PRODUCT OF THE AMIDES, FOR HIGH RESOLUTION, REDUCED CURLING | XEROX CORPORATION (US) | 1997-12-02 | — | — | US | claimed |
| US-20160243077-A1 | COMPOSITIONS AND METHODS TO IMPROVE THE THERAPEUTIC BENEFIT OF INDIRUBIN AND ANALOGS THEREOF, INCLUDING MEISOINDIGO | BROWN DENNIS M (US) | 2016-08-25 | — | — | US | disclosed |
| US-20150087687-A1 | COMPOSITIONS AND METHODS TO IMPROVE THE THERAPEUTIC BENEFIT OF INDIRUBIN AND ANALOGS THEREOF, INCLUDING MEISOINDIGO | BROWN DENNIS (US) | 2015-03-26 | — | — | US | disclosed |
| US-20100132253-A1 | FUEL ADDITIVES AND FUEL COMPOSITIONS AND METHODS FOR MAKING AND USING THE SAME | TACONIC ENERGY, INC. (US) | 2010-06-03 | — | — | US | disclosed |
| US-5851274-A | Ink jet ink compositions and processes for high resolution and high speed printing | XEROX CORPORATION (US) | 1998-12-22 | — | — | US | disclosed |
| EP-0853107-A1 | Ink jet ink compositions comprising hydroxyamide derivatives and printing processes | XEROX CORPORATION (US) | 1998-07-15 | — | — | EP | disclosed |
| EP-0853108-A1 | Ink jet ink compositions and processes for high resolution and high speed printing | XEROX CORPORATION (US) | 1998-07-15 | — | — | EP | disclosed |
| US-5693129-A | AQUEOUS MIXCTURE CONTAINING COLORING AND A HYDROXYAMIDE, THIOAMIDE, MERCAPTOAMIDE, MERCAPTOTHIOAMIDE OR AN OXYALKYLENE OR A THIOALKYLENE REACTION PRODUCT OF THE AMIDES, FOR HIGH RESOLUTION, REDUCED CURLING | XEROX CORPORATION (US) | 1997-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100132253-A1 | FUEL ADDITIVES AND FUEL COMPOSITIONS AND METHODS FOR MAKING AND USING THE SAME | FADS1, ELOVL1, FASN | ALDH1A1 281/4885HPGD 2587/4885CA12 3499/4885 |
| US-20150087687-A1 | COMPOSITIONS AND METHODS TO IMPROVE THE THERAPEUTIC BENEFIT OF INDIRUBIN AND ANALOGS THEREOF, INCLUDING MEISOINDIGO | CYP7A1, CYP3A7, UGT2B7 | ALDH1A1 455/4885HPGD 252/4885CA12 2156/4885 |
| US-20160243077-A1 | COMPOSITIONS AND METHODS TO IMPROVE THE THERAPEUTIC BENEFIT OF INDIRUBIN AND ANALOGS THEREOF, INCLUDING MEISOINDIGO | NEK9, NEK7, NEK3 | ALDH1A1 2624/4885HPGD 927/4885CA12 4377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.